- Home
- IREN vs APLS Comparison
IREN vs APLS Comparison
Compare IREN & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IREN
- APLS
- Stock Information
- Founded
- IREN 2018
- APLS 2009
- Country
- IREN Australia
- APLS United States
- Employees
- IREN N/A
- APLS N/A
- Industry
- IREN EDP Services
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- IREN Technology
- APLS Health Care
- Exchange
- IREN Nasdaq
- APLS Nasdaq
- Market Cap
- IREN 3.1B
- APLS 3.6B
- IPO Year
- IREN 2021
- APLS 2017
- Fundamental
- Price
- IREN $10.88
- APLS $27.52
- Analyst Decision
- IREN Strong Buy
- APLS Buy
- Analyst Count
- IREN 12
- APLS 18
- Target Price
- IREN $18.73
- APLS $46.71
- AVG Volume (30 Days)
- IREN 16.9M
- APLS 1.4M
- Earning Date
- IREN 02-12-2025
- APLS 02-28-2025
- Dividend Yield
- IREN N/A
- APLS N/A
- EPS Growth
- IREN N/A
- APLS N/A
- EPS
- IREN N/A
- APLS N/A
- Revenue
- IREN $285,765,000.00
- APLS $715,216,000.00
- Revenue This Year
- IREN $190.86
- APLS $97.25
- Revenue Next Year
- IREN $83.60
- APLS $12.68
- P/E Ratio
- IREN N/A
- APLS N/A
- Revenue Growth
- IREN 133.25
- APLS 162.10
- 52 Week Low
- IREN $4.15
- APLS $24.34
- 52 Week High
- IREN $15.92
- APLS $71.90
- Technical
- Relative Strength Index (RSI)
- IREN 42.85
- APLS 38.99
- Support Level
- IREN $12.53
- APLS $26.84
- Resistance Level
- IREN $13.62
- APLS $28.59
- Average True Range (ATR)
- IREN 0.93
- APLS 1.12
- MACD
- IREN -0.01
- APLS -0.03
- Stochastic Oscillator
- IREN 37.01
- APLS 18.09
About IREN Iris Energy Limited
Iris Energy Ltd is a Bitcoin mining company. It builds, owns, and operates data centers and electrical infrastructure for the mining of Bitcoin powered by renewable energy. The company's mining operations generate revenue by earning Bitcoin through a combination of block rewards and transaction fees from the operation of its specialized computers called Application-specific Integrated Circuits and exchanging these Bitcoin for currencies such as USD or CAD on a daily basis.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.